IRIS
DI IOIA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.587
EU - Europa 1.646
AS - Asia 1.452
SA - Sud America 151
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 6
Totale 5.869
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.541
SG - Singapore 513
CN - Cina 470
DE - Germania 243
IE - Irlanda 226
IT - Italia 226
UA - Ucraina 182
GB - Regno Unito 168
TR - Turchia 159
SE - Svezia 146
RU - Federazione Russa 142
BR - Brasile 130
VN - Vietnam 129
FI - Finlandia 112
FR - Francia 112
IN - India 68
CA - Canada 39
HK - Hong Kong 20
CZ - Repubblica Ceca 18
BE - Belgio 12
JP - Giappone 12
PL - Polonia 12
BD - Bangladesh 11
IQ - Iraq 10
NL - Olanda 10
CH - Svizzera 9
ZA - Sudafrica 9
PK - Pakistan 8
ES - Italia 7
EU - Europa 7
AR - Argentina 6
AU - Australia 6
ID - Indonesia 6
MX - Messico 6
SA - Arabia Saudita 6
JO - Giordania 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
IR - Iran 4
KR - Corea 4
MA - Marocco 4
PH - Filippine 4
VE - Venezuela 4
MY - Malesia 3
PY - Paraguay 3
UZ - Uzbekistan 3
AM - Armenia 2
AT - Austria 2
CL - Cile 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PE - Perù 2
RO - Romania 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.869
Salva come PNG Salva come JPEG
Città #
Singapore 381
Chandler 288
San Jose 253
Jacksonville 251
Dublin 223
Ashburn 186
Dallas 169
Beijing 142
Munich 139
Southend 116
Princeton 94
The Dalles 88
Nanjing 85
Ann Arbor 76
Izmir 73
Chieti 71
Council Bluffs 65
New York 63
Dearborn 62
Los Angeles 59
Helsinki 53
Santa Clara 48
Ho Chi Minh City 47
Wilmington 40
Cambridge 39
Altamura 32
Nanchang 29
Moscow 28
Tongling 27
Hanoi 26
Boardman 21
Hong Kong 18
São Paulo 18
Washington 18
Woodbridge 18
Frankfurt am Main 17
Montreal 17
Turku 17
Redondo Beach 16
Grevenbroich 15
Brno 14
Buffalo 14
Kunming 14
Shenyang 13
Brussels 12
Denver 12
Guangzhou 12
Jiaxing 12
London 12
Orem 12
Hebei 11
Norwalk 11
Tianjin 11
Tokyo 11
Toronto 11
Amsterdam 10
Atlanta 9
Brooklyn 9
Hangzhou 9
Houston 9
San Francisco 9
Stockholm 9
Warsaw 9
Baghdad 8
San Mateo 8
Changsha 7
Fermo 7
Monmouth Junction 7
Nuremberg 7
Phoenix 7
Chennai 6
Dong Ket 6
Falls Church 6
Fribourg 6
Jinan 6
Lanzhou 6
Poplar 6
Amman 5
Belgrade 5
Camerino 5
Manchester 5
Mumbai 5
Pescara 5
Roseto Degli Abruzzi 5
Seattle 5
Ankara 4
Boston 4
Changchun 4
Curitiba 4
Da Nang 4
Edinburgh 4
Hanover 4
Johannesburg 4
Montesilvano Marina 4
Olomouc 4
Rome 4
San Vito Chietino 4
Teramo 4
Zhengzhou 4
Ardabil 3
Totale 3.875
Salva come PNG Salva come JPEG
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 355
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 218
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 188
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 168
Cleavage of cystatin C is not associated with multiple sclerosis 167
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 165
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 162
Increasing age at disability milestones among MS patients in the MSBase Registry 153
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 149
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 148
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 148
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 147
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 141
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 141
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 141
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 140
Data of safety in a single-center alemtuzumab treated population 140
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 137
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 136
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 136
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 134
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 134
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 126
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 125
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 123
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 122
JCV-Ab serostatus in MS patients treated with Natalizumab 121
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 118
Nail loss after teriflunomide treatment: a new potential adverse event 117
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 116
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 115
Natalizumab-associated PML-IRIS: the Chieti experience. 113
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 112
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 109
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 107
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 106
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 96
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 96
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 96
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 96
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 95
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 93
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 81
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 78
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 75
Totale 5.984
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.097
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.097
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022232 4 4 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025979 50 103 110 11 23 63 94 52 103 44 164 162
2025/20261.840 163 41 234 246 202 92 307 89 186 137 102 41
Totale 5.984